Genetic epidemiology of breast cancer: Segregation analysis of 389 Icelandic pedigrees

Genetic Epidemiology

Volumn 18, Issue 1, 2000, Pages 81-94

  Baffoe Bonnie, Agnes B ^b,c   Beaty, Terri H ^a   Bailey Wilson, Joan E ^c   Kiemeney, Lambertus A L M ^e   Sigvaldason, Helgi ^d   Ólafsdóttir, Gudridur ^d   Tryggvadóttir, Laufey ^d   Tulinius, Hrafn ^d  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d ICELANDIC CANCER SOCIETY   (Iceland)

^e NONE

Author keywords

BRCA2; Iceland; Mendelian inheritance; Population based study; Segregation analyses

Indexed keywords

BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER REGISTRY; CANCER RISK; FEMALE; GENETIC EPIDEMIOLOGY; HETEROZYGOTE; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; MALE; PEDIGREE; SEGREGATION ANALYSIS;

AGE OF ONSET; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; ICELAND; MIDDLE AGED; MODELS, STATISTICAL; PEDIGREE;

EID: 0033986316     PISSN: 07410395     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2272(200001)18:1<81::AID-GEPI6>3.0.CO;2-H     Document Type: Article

References (58)

1. Akaike H. 1974. A new look at the statistical model identification. IEEE Trans Automatic Control. AC-19:716-723.
2. American Cancer Society. 1994. Cancer Facts and Figures. Atlanta: ACS.
3. Amos CI, Goldstein AM, Harris EL. 1991. Familiality of breast cancer and socio-economic status in blacks. Cancer Res 51:1793-1797.
4. Andersen TI. 1996. Genetic heterogeneity in breast cancer susceptibility. Acta Oncol 35:407-410.
5. Arason A, Barkardottir RB, Egilsson V. 1993. Linkage analysis of chromosome 17q markers and breast-ovarian cancer in Icelandic families, and possible relationship to prostatic cancer. Am J Hum Genet 52:711-717.
6. Baffoe-Bonnie AB. 1997. A genetic epidemiologic approach to studying the relationship between prostate cancer and breast cancer. Doctor of Philosophy Disseration, Johns Hopkins University, Baltimore, MD.
7. Bailey-Wilson JE, Cannon LA, King M-C. 1986. Genetic analysis of human breast cancer: a synthesis of contribution of GAW IV. Genet Epidemiol Suppl 1:15-35.
8. Barkardottir RB, Arason A, Egilsson V, Gudmundsson V, Jonasdottir AS, Johannesdottir G. 1995. Chromosome 17q-linkage seems to be infrequent in Icelandic families at risk of breast cancer. Acta Oncol 34:657-662.
9. Bishop DT. 1994. BRCA1, BRCA2, BRCA3....a myriad of breast cancer genes. Eur J Cancer 30A: 1738-1739.
10. Bishop DT, Gardner E. 1980. Analysis of the genetic predisposition to cancer in individual pedigrees. In: Cairns J, Lyon JL, Skolnick M, editors. Cancer incidence in defined populations: Banbury Report 4. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, p 389-408.
11. Bishop DT, Cannon-Albright L, McLellan T, Gardner EJ, Skolnick MH. 1988. Segregation and linkage analysis of nine Utah breast cancer pedigrees. Genet Epidemiol 5:151-169.
12. Bondy ML, Lustbader ED, Buffler PA, Schull WJ, Hardy RJ, Strong LC. 1991. Genetic epidemiology of childhood brain tumors. Genet Epidemiol 8:253-267.
13. Bonney GE. 1986. Regressive logistic models for familial diseases and other binary traits. Biometrics 42:611-625.
14. Cannings C, Thompson EA. 1977. Ascertainment in the sequential sampling of pedigrees. Clin Genet 12:208-212.
15. Cannings C, Thompson EA, Skolnick MH. 1978. Probability functions on complex pedigrees. Adv Appl Prob 10:26-61.
16. Chang-Claude J, Becher H, Eby N, Bastert G, Wharendorf J, Hamann U. 1997. Modifying effect of reproductive risk factors on the age at onset of breast cancer for German BRCA1 mutation carriers. J Cancer Res Clin Oncol 123:272-279.
17. Chen PL, Sellers TA, Rich SS, Potter JD, Folsom AR. 1995. Segregation analysis of breast cancer in a population-based sample of postmenopausal probands: Iowa Women's Health Study. Genet Epidemiol 12:401-415.
18. Claus EB, Risch N, Thompson WD. 1991. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 48:232-242.
19. Eccles D, Marlow A, Royle G, Collins A, Morton NE. 1994. Genetic epidemiology of early onset breast cancer. J Med Genet 31:944-949.
20. Elson RC. 1981. Segregation analysis. Adv Human Genet 11:63-120.
21. Elston RC, George VT. 1989. Age at diagnosis, age at examination, and other covariates in the analysis of family data. Genet Epidemiol 6:217-220.
22. Elston RC, Sobel E. 1979. Sampling considerations in the gathering and analyses of pedigree data. Am J Hum Genet 27:31-45.
23. Elston RC, Stewart J. 1971. A general model for the genetic analysis of pedigree data. Hum Hered 21:523-542.
24. Elston RC, Yelverton KC. 1975. General models for segregation analysis of pedigree data. Am J Hum Genet 31:62-69.
25. Essioux L, Abel L, Bonaiti-Pellie C. 1995. Genetic epidemiology of breast cancer: interest in survival analysis methods. Ann Hum Genet 3:271-82.
26. Eyfjord JE, Thorlacius S. 1992. Genetic changes in breast carcinomas in an Icelandic population. Pharmacogenetics 2:309-316.
27. Ford D, Easton DF. 1995. The genetics of breast and ovarian cancer. Br J Cancer 72:805-812.
28. Ford D, Easton DF, Peto J. 1995. Estimates of the gene frequency of BRCA1 and its contribution to breast cancer incidence. Am J Hum Genet 57:1457-1462.
29. Ford D, Easton DE, Stratton M, Narod S, Goldgar D, Devilee P, Bishop T, Weber B, et al. 1998. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62:676-689.
30. Friedman LS, Szabo CI, Ostermeyer EA, Dowd P, Butler L, Park T, Lee MK, Goode EL, Rowell SE, King MC. 1995. Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. Am J Hum Genet 57:1284-1297.
31. Go RCP, Elston RC, Kaplan EB. 1978. Efficiency and robustness of pedigree segregation analysis. Am J Hum Genet 30:28-37.
32. Go RCP, King MC, Bailey-Wilson J, Elston RC, Lynch HT 1983. Genetic epidemiology of breast cancer and associated cancers in high-risk families. I. Segregation analysis. J Natl Cancer Inst 71:455-461.
33. Goldstein AM, Amos CI. 1990. Segregation analysis of breast cancer from the cancer and steroid hormone study histologic subtypes. J Natl Cancer Inst 82:1911-1917.
34. Goldstein AM, Haile RWC, Marazita ML, Paganini-Hill A, Spence MA. 1987. A genetic epidemiologic investigation of breast cancer in families with bilateral breast cancer. I. Segregation analysis. J Natl Cancer Inst 78:911-918.
35. Goldstein AM, Haile RWC, Hodge SE, Paganini-Hill A, Spence MA. 1988. Possible heterogeneity in the segregation pattern of breast cancer. Genet Epidemiol 5:121-133.
36. Gudmundsson V, Johannesdottir G, Arason A, Bergthorsson JT, Ingvarsson S, Egilsson V, Barkardottir RB. 1996a. Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12q13. Cancer Res 55:4830-4832.
37. Gudmundsson V, Johannesdottir G, Arason A, Bergthorsson JT, Ingvarsson S, Egilsson V, Barkardottir RB. 1996b. Frequent occurrence of BRCA2 linkage in Icelandic breast cancer families and segregation of a common BRCA2 haplotype. Am J Hum Genet 58:749-756.
38. Iselius L, Slack J, Littler M, Morton NE. 1991. Genetic epidemiology of breast cancer in Britain. Ann Hum Genet 2:151-159.
39. Jonasson JG, Agnarsson BA, Thorlacius S, Eyfjord JE, Tulinius H. 1996. Male breast cancer in Iceland. Intl J Cancer 65:446-449.
40. Narod SA, Goldgar D, Cannon-Albright L, Weber B, Moslehi R, Ives E, Lenoir G, Lynch H. 1995. Risk modifiers in carriers of BRCA1 mutations. Intl J Cancer 64:394-398.
41. Newman B, Austin MA, Lee M, King MC. 1988. Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. Proc Natl Acad Sci USA 85:1-5.
42. Rebbeck TR, Couch FJ, Kant J, Calzone K, DeShano M, Peng Y, Chen K, Garber JE, Weber BL. 1996. Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2. Am J Hum Genet 59:547-553.
43. SAGE. 1997. Statistical analysis for genetic epidemiology, release 3.1. Computer program package available from the Department of Epidemiology and Biostatistics, Rammelkamp Center for Education and Research, MetroHealth Campus, Case Western Reserve University, Cleveland, Ohio.
44. Seitz S, Rhode K, Bender E, Nothnagel A, Kolble K, Schlag PM, Scherneck S. 1997. Strong indication for a breast cancer susceptibility gene on chromosome 8p12-22: linkage analysis in German breast cancer families. Oncogene 14:714-743.
45. Skolnick MH, Frank T, Shattuck-Eidens D, Tavtigian S. 1997. Genetic susceptibility to breast and ovarian cancer. Pathol Biol 45:245-249.
46. Sokal RR, Rohlf FJ. 1966. Biometry: principles and practice of statistics in biological research. San Francisco: WH Freeman and Company, p 112-172.
47. Stratton MR, Wooster R. 1996. Hereditary predisposition to breast cancer. Curr Opin Genet Dev 6:93-97.
48. Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, Merajver S, Thorlacius S, Offit K, Stoppa-Lyonnet D, Belanger C, Bell R, Berry S, Bogden R, Chen Q, Davis T, Dumont M, Frye C, Hattier T, Jammulapati S, Janecki T, Jiang P, Kehrer R, Leblanc JF, Mitchell JT, McArthur-Morrison J, Nguyen K, Peng Y, Samson C, Schroeder M, Snyder SC, Steele L, Stringfellow M, Stroup C, Swedlund B, Swenson J, Teng D. Thomas A, Tran T, Tran T, Tranchant M, Weaver-Feldhaus J, Wong AKC, Shizuya H, Eyfjord JE, Cannon-Albright L, Labrie F, Skolnick MH, Weber B, Kamb A, Goldgar DE. 1996. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nature Genet 12:333-337.
49. Thorlacius S, Trygvadottir L, Olafsdottir GH, Jonasson JG, Ogmundsdottir HM, Tulinius H, Eyford JE. 1995. Linkage to BRCA2 region in hereditary male breast cancer. Lancet 346:544-545.
50. Thorlacius S, Olafsdottir GH, Trygvadottir L, Neuhausen S, Jonasson JC, Tavtigian SV, Tulinius H, Ogmundsdottir HM, Eyford JE. 1996. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nature Genet 13:117-119.
51. Thorlacius S, Sigurdsson S, Bjarnadottir H, Olafsdottir GH, Jonasson JG, Trygvadottir L, Tulinius H, Eyford JE. 1997. Study of a single BRCA2 mutation with high carrier frequency in a small population. Am J Hum Genet 60:1079-1084.
52. Tryggvadóttir L, Tulinius H, Robertson JM. 1988. Familial and sporadic breast cancer cases in Iceland: a comparison related to ABO blood groups and risk of bilateral breast cancer. Int J Cancer 42:499-501.
53. Tulinius H, Day NE, Bjarnason O, Geirsson G, Licaega de Gonzalez MA, Sigvaldason H, Bjarnadottir G, Grimsdottir K. 1982. Familial breast cancer in Iceland. Int J Cancer 29:365-371.
54. Tulinius H, Bjarnason O, Sigvaldason H, Bjarnadottir G, Olafsdottir G, Bjarnason T. 1987. Cancer incidence in Iceland 1973-82. In: Muir C, Waterhouse J, Mack T, Powel J, Whelan S, editors. Cancer incidence in five continents. Volume V. Lyon: IARC Scientific publication no. 88.
55. Tulinius H, Sigvaldalson H, Olafsdottir G, Tryggvadóttir L. 1992a. Epidemiology of breast cancer in families in Iceland. J Med Genet 29:158-164.
56. Tulinius H, Egilsson V, Olafsdottir GH, Sigvaldalson H. 1992b. Risk of prostate, ovarian and endometrial cancer among relatives of women with breast cancer. Br Med J 305:855-857.
57. Williams WR, Anderson DE. 1984. Genetic epidemiology of breast cancer: segregation analysis of 200 Danish pedigrees. Genet Epidemiol 1:7-20.
58. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Rice C, Biggs P, Hashim Y, Smith A, Connor F, Arason A, Gudmundsson J, Ficenec D, Kelsell D, Ford D, Tonin P. 1995. Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-792.